Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
NCT01025934 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2009-12-04
Summary
The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.
Conditions
- Proliferative Diabetic Retinopathy
Interventions
- DRUG
- OTHER
-
sham
Sponsors & Collaborators
-
Napoli CTO Hospital
collaborator UNKNOWN -
University of Campania Luigi Vanvitelli
lead OTHER
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
More Related Trials
-
Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
NCT00802126 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT01724385 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
NCT00524875 ·Status: UNKNOWN ·Phase: NA
-
Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy
NCT06899529 ·Status: RECRUITING ·Phase: NA
-
Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy
NCT01920984 ·Status: COMPLETED ·Phase: NA
-
Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
NCT05514925 ·Status: UNKNOWN ·Phase: PHASE4
-
Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy
NCT00745498 ·Status: COMPLETED ·Phase: NA
-
Bevacizumab and Long Acting Gas in Diabetic Vitrectomy
NCT00656435 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy
NCT01976923 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab in Agioid Streaks
NCT00406250 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
NCT00370721 ·Status: UNKNOWN ·Phase: PHASE3
-
Preoperative Bevacizumab for Vitreous Hemorrhage
NCT00596297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy
NCT00596505 ·Status: COMPLETED
-
IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes
NCT06559488 ·Status: COMPLETED ·Phase: NA
-
VEGF and PEDF in Patients With Myopic Choroidal Neovascularization
NCT02175940 ·Status: COMPLETED
-
Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease
NCT01041690 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
NCT01327222 ·Status: COMPLETED ·Phase: PHASE3
-
Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization
NCT01350323 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
NCT02015351 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation
NCT00673296 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
NCT00967850 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
NCT04511715 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab for Diabetic Macular Edema
NCT00703235 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab
NCT04138420 ·Status: COMPLETED